Preoperative Prognostic Nutritional Index was not predictive of short-term complications after laparoscopic resection for rectal cancer.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
04 Jul 2023
Historique:
received: 07 11 2022
accepted: 29 05 2023
medline: 6 7 2023
pubmed: 4 7 2023
entrez: 4 7 2023
Statut: epublish

Résumé

Prognostic Nutritional Index (PNI) is a useful tool to predict short-term results in patients undergoing surgery for gastrointestinal cancer. Few studies have addressed this issue in colorectal cancer or specifically in rectal cancer. We evaluated the prognostic relevance of preoperative PNI on morbidity of patients undergoing laparoscopic curative resection for rectal cancer (LCRRC). PNI data and clinico-pathological characteristics of LCRRC patients (June 2005-December 2020) were evaluated. Patients with metastatic disease were excluded. Postoperative complications were evaluated using the Clavien-Dindo classification. A total of 182 patients were included in the analysis. Median preoperative PNI was 36.5 (IQR 32.8-41.2). Lower PNI was associated with females (p=0.02), older patients (p=0.0002), comorbidity status (p<0.0001), and those who did not receive neoadjuvant treatment (p=0.01). Post-operative complications occurred in 53 patients (29.1%), by the Clavien-Dindo classification: 40 grades I-II and 13 grades III-V. Median preoperative PNI was 35.0 (31.8-40.0) in complicated patients and 37.0 (33.0-41.5) in uncomplicated patients (p=0.09). PNI showed poor discriminative performance regarding postoperative morbidity (AUC 0.57) and was not associated with postoperative morbidity (OR 0.97) at multivariable analysis. Preoperative PNI was not associated with postoperative morbidity after LCRRC. Further research should focus on different nutritional indicators or hematological/immunological biomarkers.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Prognostic Nutritional Index (PNI) is a useful tool to predict short-term results in patients undergoing surgery for gastrointestinal cancer. Few studies have addressed this issue in colorectal cancer or specifically in rectal cancer. We evaluated the prognostic relevance of preoperative PNI on morbidity of patients undergoing laparoscopic curative resection for rectal cancer (LCRRC).
METHODS METHODS
PNI data and clinico-pathological characteristics of LCRRC patients (June 2005-December 2020) were evaluated. Patients with metastatic disease were excluded. Postoperative complications were evaluated using the Clavien-Dindo classification.
RESULTS RESULTS
A total of 182 patients were included in the analysis. Median preoperative PNI was 36.5 (IQR 32.8-41.2). Lower PNI was associated with females (p=0.02), older patients (p=0.0002), comorbidity status (p<0.0001), and those who did not receive neoadjuvant treatment (p=0.01). Post-operative complications occurred in 53 patients (29.1%), by the Clavien-Dindo classification: 40 grades I-II and 13 grades III-V. Median preoperative PNI was 35.0 (31.8-40.0) in complicated patients and 37.0 (33.0-41.5) in uncomplicated patients (p=0.09). PNI showed poor discriminative performance regarding postoperative morbidity (AUC 0.57) and was not associated with postoperative morbidity (OR 0.97) at multivariable analysis.
CONCLUSIONS CONCLUSIONS
Preoperative PNI was not associated with postoperative morbidity after LCRRC. Further research should focus on different nutritional indicators or hematological/immunological biomarkers.

Identifiants

pubmed: 37402015
doi: 10.1007/s00423-023-02962-w
pii: 10.1007/s00423-023-02962-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

263

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249
doi: 10.3322/caac.21660 pubmed: 33538338
Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, Arnold M (2019) Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 144:2992–3000
doi: 10.1002/ijc.32055 pubmed: 30536395
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 69:613–616
doi: 10.1002/bjs.1800691019 pubmed: 6751457
Slaney G (1971) Results of treatment for carcinoma of the colon and rectum. Mod Trends Surg 3:69–89
pubmed: 5120472
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646
doi: 10.1056/NEJMoa010580 pubmed: 11547717
Law WL, Choi HK, Lee YM (2007) Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy. J Gastrointest Surg 11:8–15
doi: 10.1007/s11605-006-0049-z pubmed: 17390180
Aritinian A, Orcutt TS, Anaya AD et al (2015) Infectious post-operative complications decrease long term survival in patients undergoing curative surgery for colorectal cancer. A study of 12,075 patients. Ann Surg 261:497–505
doi: 10.1097/SLA.0000000000000854
Filip B, Scarpa M, Cavallin F, Cagol M, Alfieri R, Saadeh L, Ancona E, Castoro C (2015) Postoperative outcome after oesophagectomy for cancer: nutritional index score is the missing ring in the current prognostic scores. Eur J Surg Oncol 41:787–794
doi: 10.1016/j.ejso.2015.02.014 pubmed: 25890494
Watanabe M, Iwatsuki M, Iwagami S, Ishimoto T, Baba Y, Baba H (2012) Prognostic Nutritional Index predicts outcomes of gastrectomy in the elderly. World J Surg 36:1632–1639
doi: 10.1007/s00268-012-1526-z pubmed: 22407085
Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98:268–274
doi: 10.1002/bjs.7305 pubmed: 20960457
Pinato DJ, North BV, Sharma R (2012) A novel externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the Prognostic Nutritional Index (PNI). Br J Cancer 106:1439–1144
doi: 10.1038/bjc.2012.92 pubmed: 22433965 pmcid: 3326674
Tokunaga R, Sakamoto Y, Nakagawa S, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H (2015) Prognostic Nutritional Index predicts complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum 58:1048–1057
doi: 10.1097/DCR.0000000000000458 pubmed: 26445177
Jian-Hui C, Iskandar EA, Cai S, Chen C, Wu H, Xu J, He Y (2016) Significance of Onodera’s Prognostic Nutritional Index in patients with colorectal cancer: a large cohort study in a single Chinese institution. Tumor Biol 37:3277–3283
doi: 10.1007/s13277-015-4008-8
Mohri Y, Inohue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M (2013) Prognostic Nutritional Index predicts postoperative outcome in colorectal cancer. World J Surg 37:2688–2692
doi: 10.1007/s00268-013-2156-9 pubmed: 23884382
Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao J, Sun J, Xu Y, Wang Z (2016) Prognostic significance of preoperative Prognostic Nutritional Index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget 7:58543–58552
doi: 10.18632/oncotarget.10148 pubmed: 27344182 pmcid: 5295450
Onodera T, Goseki N, Kosaki G (1984) Prognostic Nutritional Index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005
pubmed: 6438478
Miyakita H, Sadahiro S, Saito G, Okada K, Tanaka A, Suzuki T (2017) Risk scores as useful predictors of perioperative complications in patients with rectal cancer who received radical surgery. Int J Clin Oncol 22:324–331
doi: 10.1007/s10147-016-1054-1 pubmed: 27783239
Xia LJ, Li W, Zhai JC, Yan CW, Chen JB, Yang H (2020) Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and Prognostic Nutritional Index for predicting clinical outcomes in T1-2 rectal cancer. BMC Cancer 20:208
doi: 10.1186/s12885-020-6698-6 pubmed: 32164623 pmcid: 7066735
Al-Homoud S, Purkayastha S, Aziz O, Smith JJ, Thompson MD, Darzi AW, Stamatakis JD, Tekkis PP (2004) Evaluating operative risk in colorectal cancer surgery: ASA and POSSUM-based predictive models. Surg Oncol 13:83–92
doi: 10.1016/j.suronc.2004.08.006 pubmed: 15572090
Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251
doi: 10.1016/0895-4356(94)90129-5 pubmed: 7722560
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/ . Accessed 31 Jan 2023
https://www.registrotumoriveneto.it/it/dati/dati-per-sede (accessed September 30, 2022)
Subwongcharoen S, Areesawangvong P, Chompoosaeng T (2019) Impact of nutritional status on surgical patients. Clin Nutr ESPEN 32:135–139
doi: 10.1016/j.clnesp.2019.03.016 pubmed: 31221278
Li D, Jensen CC (2019) Patient satisfaction and quality of life with enhanced recovery protocols. Clin Colon Rectal Surg 32:138–144
doi: 10.1055/s-0038-1676480 pubmed: 30833864 pmcid: 6395092
Portale G, Spolverato Y, Bartolotta P, Gregori D, MAzzeo A, Rettore C, Cancian L, Fiscon V, (2023) Skeletal muscle mass and surgical morbidity after laparoscopic rectal cancer resection. J Laparoendosc Adv Surg Tech A 33(6):570–578. https://doi.org/10.1089/lap.2023.0068
doi: 10.1089/lap.2023.0068 pubmed: 37130330
Jochum SB, Kistner M, Wood EH et al (2019) Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer. Colorectal Dis 21:1372–1378
doi: 10.1111/codi.14751 pubmed: 31276286
Uehara H, Yamazaki T, Kaneyama H et al (2022) Is radiological psoas muscle area measurement a predictor of postoperative complications after rectal resection for cancer? A retrospective study. Surg Today 52:306–315
doi: 10.1007/s00595-021-02346-x pubmed: 34309711
Takeda Y, Akiyoshi T, Matsueda K et al (2018) Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 21:1372–1378
Chen XY, Yin SY, Shen YT, Zhang XC, Chen KK, Zhou CJ, Zheng CG (2022) The geriatric nutritional risk index is an effective tool to detect GLIM-defined malnutrition in rectal cancer patients. Front Nutr 15(9):1061944
doi: 10.3389/fnut.2022.1061944
Bausys A, Kryzauskas M, Abeciunas V, Degutyte AE, Bausys R, Strupas K, Poskus T (2022) Prehabilitation in modern colorectal cancer surgery: a comprehensive review. Cancers 13(14):5017
doi: 10.3390/cancers14205017
Franssen RF, Bongers BC, Vongelaar FJ, Janssen-Heijnen ML (2022) Feasibility of a tele-prehabilitation program in high-risk patients with colon or rectal cancer undergoing elective surgery: a feasibility study. Perioper Med 26(11):28
doi: 10.1186/s13741-022-00260-5

Auteurs

Giuseppe Portale (G)

Department of General Surgery, Azienda ULSS 6 'Euganea' Padova, Via Casa di Ricovero, 40, 35013, Cittadella, Padua, Italy. portale.giuseppe@ibero.it.

Francesco Cavallin (F)

Independent Statistician, Solagna, Vicenza, Italy.

Chiara Cipollari (C)

Department of General Surgery, Azienda ULSS 6 'Euganea' Padova, Via Casa di Ricovero, 40, 35013, Cittadella, Padua, Italy.

Ylenia Spolverato (Y)

Department of General Surgery, Azienda ULSS 6 'Euganea' Padova, Via Casa di Ricovero, 40, 35013, Cittadella, Padua, Italy.

Diletta Di Miceli (D)

Department of General Surgery, Azienda ULSS 6 'Euganea' Padova, Via Casa di Ricovero, 40, 35013, Cittadella, Padua, Italy.

Matteo Zuin (M)

Department of General Surgery, Azienda ULSS 6 'Euganea' Padova, Via Casa di Ricovero, 40, 35013, Cittadella, Padua, Italy.

Antonio Mazzeo (A)

Department of General Surgery, Azienda ULSS 6 'Euganea' Padova, Via Casa di Ricovero, 40, 35013, Cittadella, Padua, Italy.

Alberto Morabito (A)

Department of Oncology, Azienda ULSS 6 'Euganea', Cittadella, Italy.

Teodoro Sava (T)

Department of Oncology, Azienda ULSS 6 'Euganea', Cittadella, Italy.

Valentino Fiscon (V)

Department of General Surgery, Azienda ULSS 6 'Euganea' Padova, Via Casa di Ricovero, 40, 35013, Cittadella, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH